{"url_path":"/sec/gri/8-k/2026-05-14/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1824293/0001824293-26-000046-index.html","accession_number":"0001824293-26-000046","cik":"0001824293","ticker":"GRI","issuer_name":"GRI Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1824293/0001824293-26-000046-index.html","primary_entity_key":"0001824293","primary_entity_name":"GRI Bio, Inc."},"word_count":23,"has_tables":true,"body_markdown":"Item 8.01 Other Events.\n\nThe section of the Press Release entitled “Phase 2a Data – GRI-0621 in IPF” is incorporated herein by reference."}